TIMMINS MEGAN C. 4
Research Summary
AI-generated summary
Rockwell Medical (RMTI) EVP Megan Timmins Receives RSU Award
What Happened
Megan C. Timmins, EVP, Chief Legal Officer & Secretary of Rockwell Medical (RMTI), was granted 15,000 restricted stock units (RSUs) on July 1, 2026. The award was reported at $0.00 per share (no cash paid at grant). The RSUs vest in three equal installments on the first, second and third anniversaries of July 1, 2026, subject to her continued service.
Key Details
- Transaction date and type: 2026-07-01 — Grant/Award of 15,000 RSUs (code A) at $0.00 per share.
- Vesting: 3 equal annual installments on each anniversary of July 1, 2026 (service-based).
- Shares owned after transaction: not specified in the provided excerpt; the filing notes amounts have been adjusted for a 1-for-10 reverse stock split.
- Notable footnotes:
- F1: RSUs vest in three equal installments on each annual anniversary, subject to continued service.
- F2: A 1-for-10 reverse split became effective at 12:01 AM on July 1, 2026; outstanding equity awards and reported share figures were proportionately adjusted.
- Filing timing: Form filed on 2026-07-06 for a 2026-07-01 grant (filed five days after the transaction). Form 4s are generally due within two business days of the transaction; the filing date here is later than that window.
Context
This was an equity award (RSUs), not a market purchase or sale. RSU grants are common compensation and do not by themselves indicate buying or selling market sentiment — value is realized only as units vest (and typically when converted to shares or cashed out). The reverse split adjusted the number of reported shares and awards company-wide and is purely a post-grant structural change.